The litigation centers on claims that PROCEPT BioRobotics misled the market by utilizing a discount program that encouraged customers to order handpieces far beyond actual clinical demand. According to the complaint, this practice created an unsustainable glut of over 10,000 excess units in the field. Plaintiffs argue these actions allowed the company to inflate its financial reports and issue revenue guidance for 2025 that lacked a factual foundation.
Rosen Law Firm, which filed the action, is currently soliciting participants for the class. Under the proposed timeline, the court will appoint a lead plaintiff by September 22, 2026. While the firm is actively recruiting, investors retain the right to select their own counsel or remain absent class members without taking immediate action. No class has been certified at this stage, meaning investors are not yet represented unless they formally retain an attorney.
Comments (0)
No comments yet. Be the first!